European Archives - Page 89 of 1325 - European Medical Journal

Rare Genetic Variants Linked to Severe Brain Disease After Chickenpox

Rare genetic variants affecting antiviral, inflammatory, and autophagy pathways may explain severe neurological complications from chickenpox in children.

Ultrasound Tool Offers New Insight Into Autoimmune Lung Disease

A new study demonstrates that a modified lung ultrasound (LUS) scoring system can accurately assess severity and prognosis in systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD).

Upadacitinib Shows Promise for Moderate-to-Severe HS Treatment

Patients receiving once-daily upadacitinib 30 mg achieved significantly greater reductions in abscesses and inflammatory nodules compared with historical placebo rates.

The ISCHEMIA Trial: Invasive Strategy Relieves Angina Faster

Invasive strategy helps relieve angina faster in chronic coronary disease, while conservative care prolongs persistent symptoms, study finds.

Rob Pieters

Hema Now: Episode 25: The Future of Childhood Cancer

Catherine Glass chats with Rob Pieters, Professor of Pediatric Oncology and co-founder of the Princess Máxima Center, Europe’s largest childhood cancer center.

Ancient Conch Shell Practice Shows Promise in Sleep Apnoea Care

A randomised trial finds that blowing a conch shell reduces daytime sleepiness, improves sleep quality, and lowers apnoea severity in people with obstructive sleep apnoea.

Early Salpingectomy Shows Promise in Ovarian Cancer Prevention

A new study has identified the best ways to evaluate the effectiveness of risk-reducing early salpingectomy (RRES) with delayed oophorectomy in women at high genetic risk of ovarian cancer.

How Temperature and Light Impact Sleep in Dementia

Cooler bedrooms and brighter daytimes shown to promote better sleep and wellbeing in people living with dementia, new study reveals.

PCOS Increases Risk of Cardiometabolic Disease

Appropriate risk assessment before prescribing treatment, along with personalised management strategies, could help reduce the long-term burden of cardiometabolic diseases in this population.

An illustration of two people's hands shaking, wearing suits

Roche acquires US biotech 89bio for $3.5bn

Roche acquires 89bio in a $3.5bn deal, adding a late-stage MASH therapy and expanding its focus on cardiovascular and metabolic diseases.